Countries Fail to Promote Physical Activity; Study Links Exercise and Vaccine Efficacy 25/10/2022 Kerry Cullinan Most countries are failing dismally to promote physical exercise despite inactivity playing a major role in heart disease, obesity and diabetes, according to the World Health Organization (WHO). The WHO’s newly released Global status report on physical activity 2022 measures the extent to which governments are implementing recommendations to increase physical activity across all ages […] Continue reading -> Increased Self-Care Could Save $179b in Healthcare Costs 20/10/2022 Maayan Hoffman For “Nundy,” a mother of two living in South Africa’s Khayelitsha township, going to the doctor more than once a year is not an option. She would have to pay 50% of her total household income in a month in order to see a doctor, so she saves up all of her medical questions and […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Increased Self-Care Could Save $179b in Healthcare Costs 20/10/2022 Maayan Hoffman For “Nundy,” a mother of two living in South Africa’s Khayelitsha township, going to the doctor more than once a year is not an option. She would have to pay 50% of her total household income in a month in order to see a doctor, so she saves up all of her medical questions and […] Continue reading -> Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Health Systems and Cancer Services Need to Better Care for Older Adults 17/10/2022 Sonali Johnson A lack of expertise in geriatric oncology means that cancer in older adults is often confused with other signs of ageing and diagnosed too late. Dr Sonali Johnson sets out a blueprint for addressing this barrier – one of the many topics to be discussed at the World Cancer Congress, hosted by the Union for […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts
Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> Posts navigation Older postsNewer posts